Wanbangde Pharmaceutical Holding Group Co.,Ltd.’s Net Profit Dropped 53.2% in First Half of 2022

Wanbangde Pharmaceutical Holding Group Co.,Ltd. (万邦德医药控股集团股份有限公司) (002082.SZ) reported a net profit of 52.1 million yuan in the first half of 2022, down 53.2% year-on-year.

Meanwhile, the company posted 731.2 million yuan in revenue, down 21.3% year-on-year.

At the end of the reporting period, it had 4 billion yuan in total assets and 1.2 billion yuan in total liabilities, with a liability-to-asset ratio of 30.6%.